Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
abiraterone betablockers,selective

increases exposure

Unknown Study
abiraterone metoprolol

increases exposure

Unknown Study
abrocitinib ciclosporin

increases exposure

Unknown Theoretical
abrocitinib dabigatran

increases exposure

Unknown Study
abrocitinib digoxin

increases exposure

Unknown Theoretical
abrocitinib everolimus

increases exposure

Unknown Theoretical
abrocitinib sirolimus

increases exposure

Unknown Theoretical
abrocitinib thrombininhibitors

increases exposure

Unknown Study
acarbose digoxin

decreases concentration

Unknown Study
aceinhibitors azathioprine

increases risk of anaemiaand/orleucopenia

Unknown Anecdotal
aceinhibitors temsirolimus

increases risk of angioedema

Unknown Theoretical
acetazolamide antiepileptics

increases risk of overheatinganddehydration

Unknown Theoretical
acetazolamide lithium

affects concentration

Unknown Anecdotal
acetazolamide zonisamide

increases risk of overheatinganddehydration

Unknown Theoretical
aciclovir herpes-zostervaccine

decreases efficacy

Unknown Theoretical
aciclovir herpes-zostervaccine,live

decreases efficacy

Unknown Theoretical
aciclovir live

decreases efficacy

Unknown Theoretical
aciclovir livevaccines

decreases efficacy

Unknown Theoretical
acipimox fibrates

increases risk of rhabdomyolysis

Unknown Theoretical
acipimox statins

increases risk of rhabdomyolysis

Unknown Theoretical
albendazole levamisoleandlevamisolemoderatelydecreasestheexposuretoalbendazole

decreases exposure

Unknown Study
alcohol acitretin

increases concentration

Unknown Study
alcohol antiepileptics

increases risk of visualdisturbances

Unknown Study
alcohol methylphenidate

increases concentration

Unknown Study
alcohol retigabine

increases risk of visualdisturbances

Unknown Study
alcohol retinoids

increases concentration

Unknown Study
alcohol topicalpimecrolimus

increases risk of facialflushingandskinirritation

Unknown Study
alcohol topicaltacrolimus

increases risk of facialflushingandskinirritation

Unknown Study
alcohol vasopressin

decreases antidiuretic effect

Unknown Theoretical
alemtuzumab ponesimod

increases risk of generalisedinfection(possiblylife-threatening)

Unknown Theoretical
aliskiren furosemide

decreases exposure

Unknown Study
aliskiren loopdiuretics

decreases exposure

Unknown Study
allopurinol amoxicillin

increases risk of skinrash

Unknown Study
allopurinol ampicillin

increases risk of skinrash

Unknown Study
allopurinol azathioprine

increases risk of haematologicaltoxicity

Unknown Study
allopurinol capecitabine

decreases effects

Unknown Study
allopurinol mercaptopurine

increases risk of haematologicaltoxicity

Unknown Study
allopurinol penicillins

increases risk of skinrash

Unknown Study
allopurinol pyrazinamide

increases risk of hyperuricaemia

Unknown Theoretical
almotriptan ergotamine

increases risk of vasoconstriction

Unknown Theoretical
alpelisib bupropion

decreases efficacy

Unknown Theoretical
alpelisib coumarins

decreases efficacy

Unknown Theoretical
alpelisib warfarin

decreases efficacy

Unknown Theoretical
alprazolam lomitapide

increases exposure

Unknown Theoretical
aluminiumhydroxide enteralfeeds

increases risk of blockedenteralornasogastrictubes

Unknown Study
aluminiumhydroxide roxadustat

decreases exposure

Unknown Theoretical
amfetamines atomoxetine

increases risk of adverseeffects

Unknown Theoretical
aminoglycosides neostigmine

decreases effects

Unknown Theoretical
aminoglycosides neratinib

decreases concentration

Unknown Theoretical
aminoglycosides pyridostigmine

decreases effects

Unknown Theoretical
3916 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.